Loading
Latest filing published 22 Apr 2026 for XSpray Pharma AK, €11k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Anders Ekblom in XSpray Pharma AK. The record holds 23 filings, for trades running from 2 May 2023 to 21 April 2026.
Every open-market trade on record is a purchase: 7 purchases worth €1.1M, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
A typical purchase (the median) is worth €88k. Of 4 purchases, 2 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 22 April 2026, the filings show a transaction worth €11k in XSpray Pharma AK. The last purchase on record was published on 13 January 2025, which is 649 days ago. The median gap between a trade and its publication by Finansinspektionen is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations